BioVersys AG | WebDisclosure

Basculer en Français

8635	Companies
144890	Keywords
80545	Articles
77499	Press releases

Home
Companies
BioVersys AG

BRIEF

published on 04/28/2025 at 07:05, 2 days 7 hours ago

BioVersys organise un événement virtuel sur l'étude BV100 pour VABP

Événement Virtuel BioVersys AG Étude BV100 Traitement VABP Résistance Aux Carbapénèmes
BRIEF

published on 04/28/2025 at 07:05, 2 days 7 hours ago

BioVersys to Host Virtual Event on BV100 Study for VABP

Virtual Event BioVersys AG BV100 Study VABP Treatment Carbapenem Resistance
PRESS RELEASE

published on 04/28/2025 at 07:00, 2 days 8 hours ago

BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025
BioVersys AG to host virtual KOL event featuring Prof. David Paterson & Dr. Andrew Shorr on BV100 Phase 2 VABP study against CRAB. Register for insights on May 7, 2025

Virtual Event BioVersys AG Antibacterial Products Multidrug-resistant Bacteria Key Opinion Leaders
BRIEF

published on 04/08/2025 at 07:05, 22 days 7 hours ago

BioVersys présentera les données du BV100 à l'ESCMID Global 2025

Essai Clinique Résistance Aux Antibiotiques BV100 BioVersys ESCMID 2025
BRIEF

published on 04/08/2025 at 07:05, 22 days 7 hours ago

BioVersys to Showcase BV100 Data at ESCMID Global 2025

Clinical Trial Antibiotic Resistance BV100 BioVersys ESCMID 2025
PRESS RELEASE

published on 04/08/2025 at 07:00, 22 days 8 hours ago

BIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025
BioVersys to present BV100 Phase 2 data at 35th ESCMID Global 2025. Oral presentation on positive VABP trial read-out & poster presentations on Acinetobacter baumannii & NTM data

Clinical Data BV100 Antibacterial Products BioVersys ESCMID Global 2025
BRIEF

published on 03/31/2025 at 07:05, 30 days 7 hours ago

BioVersys obtient un brevet chinois pour la technologie BV100

Marché Chinois BioVersys AG Brevet BV100 Infections À Acinetobacter Formulation De Rifabutine
BRIEF

published on 03/31/2025 at 07:05, 30 days 7 hours ago

BioVersys Secures Chinese Patent for BV100 Technology

Chinese Market BioVersys AG BV100 Patent Acinetobacter Infections Rifabutin Formulation
PRESS RELEASE

published on 03/31/2025 at 07:00, 30 days 8 hours ago

BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE PATENT OFFICE
BioVersys AG announces the granting of an important BV100 patent by the Chinese Patent Office, protecting novel drug candidate technology

Patent China BioVersys AG BV100 Antibacterial
BRIEF

published on 03/26/2025 at 07:05, 1 month 4 days ago

BioVersys Outlines 2024 Achievements and Financials

2024 Financials IPO Success BioVersys AG BV100 Trial Alpibectir Studies

1 2 ... 4

Accesswire

Published on 04/30/2025 at 14:30, 32 minutes ago

Trans Canada Gold Corp. to Sell Its 18.75 % Petroleum and Natural Gas Rights and Interest in the Non-performing 8-23-049-1 W4M GP Well Only, and the GP Petroleum Zone Rights Within the AMI to Its Working Interest Partners
Published on 04/30/2025 at 14:30, 32 minutes ago

Inspire Veterinary Partners Celebrates Record Veterinary Hiring and the Appointment of Lynley Kees to Chief People Officer
Published on 04/30/2025 at 14:15, 47 minutes ago

Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease
Published on 04/30/2025 at 14:01, 1 hour 1 minute ago

Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors
Published on 04/30/2025 at 14:00, 1 hour 2 minutes ago

GameSquare Media Announces New Partnership with Esports.gg

View all ACCESSWIRE

EQS Group

Published on 04/30/2025 at 14:30, 32 minutes ago

General Assembly of the Critical Infrastructure Association of the Slovak Republic Sets Future Direction
Published on 04/30/2025 at 14:15, 47 minutes ago

GEA Annual General Meeting approves dividend increase and re-elects three Supervisory Board members
Published on 04/30/2025 at 14:09, 53 minutes ago

FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany
Published on 04/30/2025 at 14:01, 1 hour 1 minute ago

Nebius Group N.V. announces date of first quarter 2025 results and conference call
Published on 04/30/2025 at 14:00, 1 hour 2 minutes ago

VAZIVA SA: Invitation webinaire actionnaires individuels le mercredi 14 mai 2025 à 18h00 - Présentation des Résultats annuels 2024

Les Echos

Published on 04/30/2025 at 08:30, 6 hours 32 minutes ago

Mise à disposition des documents préparatoires à l’Assemblée Générale mixte
Published on 04/29/2025 at 19:13, 19 hours 49 minutes ago

Rapport Financier Annuel - 31/12/2024
Published on 04/29/2025 at 19:02, 20 hours ago

LNA SANTE : Mise à disposition du document d'enregistrement universel 2024
Published on 04/29/2025 at 18:22, 20 hours 40 minutes ago

BIO-INOX : RESULTATS ANNUELS 2024 : CHIFFRE D'AFFAIRES +16,4% - RESULTAT NET +75,1%
Published on 04/29/2025 at 18:12, 20 hours 50 minutes ago

250429 BENETEAU Avis de mise à disposition de documents

View all LES ECHOS COMFI WIRE